WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in ALXO — Alx Oncology Holdings Inc

CIK 1632972 PLYMOUTH, MN

Position in ALXO

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$78,682

+$2,499 QoQ

Shares Held

38,011

+0.0% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 94 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,074,678 across 146 Biotechnology names. ALXO ranks #116 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$78,682	38,011	+0.0%	Shares	Sole	2026-07-15
2026-03-31	$76,183	37,997	+0.0%	Shares	Sole	2026-04-08
2025-12-31	$42,930	37,992	-0.2%	Shares	Sole	2026-01-08
2025-09-30	$69,673	38,073	-3.1%	Shares	Sole	2025-10-29
2025-06-30	$16,300	39,279	-3.1%	Shares	Sole	2025-07-10
2025-03-31	$25,263	40,551	+3.6%	Shares	Sole	2025-04-16
2024-12-31	$65,348	39,131	+23.4%	Shares	Sole	2025-03-17
2024-09-30	$57,712	31,710	+0.9%	Shares	Sole	2024-10-24
2024-06-30	$189,456	31,419	—	Shares	Sole	2024-07-16
No filing history on record for this holder in this stock.